BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 9752345)

  • 21. [Aspects of molecular remission in hematology and oncology].
    Novik AA; Kamilova TA; Tsygan VN
    Vopr Onkol; 2001; 47(3):270-7. PubMed ID: 11544823
    [No Abstract]   [Full Text] [Related]  

  • 22. Malignant epithelial tumors and hematologic malignancy.
    Marković-Glamocak M; Sucić M; Ries S; Gjadrov-Kuvezdić K; Labar B
    Diagn Cytopathol; 2008 Oct; 36(10):710-4. PubMed ID: 18773444
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Different immune reconstitution in multiple myeloma, chronic myeloid leukemia and acute myeloid leukemia patients after allogeneic transplantation of peripheral blood stem cells.
    Rondelli D; Re F; Bandini G; Raspadori D; Arpinati M; Senese B; Stanzani M; Bonifazi F; Falcioni S; Chirumbolo G; Tura S
    Bone Marrow Transplant; 2000 Dec; 26(12):1325-31. PubMed ID: 11223973
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DLI or second transplant.
    Greinix HT
    Ann Hematol; 2002; 81 Suppl 2():S34-5. PubMed ID: 12611068
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Current therapy of malignant blood diseases].
    de Werra P
    Praxis; 1967 Jun; 56(26):901-6. PubMed ID: 5253422
    [No Abstract]   [Full Text] [Related]  

  • 26. [Interferon-alpha in therapy of malignant hemoblastoses].
    Schuler M; Aulitzky WE; Schneller F; Peschel C; Huber C
    Internist (Berl); 1995 Dec; 36(12):1133-8. PubMed ID: 8567218
    [No Abstract]   [Full Text] [Related]  

  • 27. The burden and outcomes associated with four leukemias: AML, ALL, CLL and CML.
    Redaelli A; Stephens JM; Laskin BL; Pashos CL; Botteman MF
    Expert Rev Anticancer Ther; 2003 Jun; 3(3):311-29. PubMed ID: 12820775
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of donor cell derived acute myeloid leukemia after stem cell transplantation for chronic myeloid leukemia.
    Pieroni F; Oliveira FM; Panepucci RA; Voltarelli JC; Simões BP; Falcão RP
    Bone Marrow Transplant; 2006 Apr; 37(8):801-2. PubMed ID: 16501585
    [No Abstract]   [Full Text] [Related]  

  • 29. Development of multiple myeloma in a patient with chronic myeloid leukemia after treatment with imatinib mesylate.
    Garipidou V; Vakalopoulou S; Tziomalos K
    Oncologist; 2005; 10(6):457-8. PubMed ID: 15967839
    [No Abstract]   [Full Text] [Related]  

  • 30. Donor cell-derived acute myeloid leukemia developing 14 months after matched unrelated bone marrow transplantation for chronic myeloid leukemia.
    Hambach L; Eder M; Dammann E; Battmer K; Stucki A; Heil G; Ganser A; Hertenstein B
    Bone Marrow Transplant; 2001 Oct; 28(7):705-7. PubMed ID: 11704795
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multiple myeloma and chronic leukaemias in 2014: improved understanding of disease biology and treatment.
    San-Miguel JF; Kantarjian HM
    Nat Rev Clin Oncol; 2015 Feb; 12(2):71-2. PubMed ID: 25511190
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current status of vaccination therapy for leukemias.
    Reichardt VL; Brossart P
    Curr Hematol Rep; 2005 Jan; 4(1):73-6. PubMed ID: 15610663
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chronic myelogenous leukemia: a review and update of therapeutic strategies.
    Garcia-Manero G; Faderl S; O'Brien S; Cortes J; Talpaz M; Kantarjian HM
    Cancer; 2003 Aug; 98(3):437-57. PubMed ID: 12879460
    [No Abstract]   [Full Text] [Related]  

  • 34. Concurrent B-cell chronic lymphocytic leukemia and multiple myeloma treated successfully with lenalidomide.
    Srinivasan S; Schiffer CA
    Leuk Res; 2009 Apr; 33(4):561-4. PubMed ID: 18676017
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Autoimmunity and second malignancy in large granular lymphocytic leukaemia.
    Bassan R; Rambaldi A; Barbui T
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():149-50. PubMed ID: 2785424
    [No Abstract]   [Full Text] [Related]  

  • 36. Co-existence of Philadelphia chromosome positive acute megakaryoblastic and B-lymphoblastic mixed blast crisis of chronic myeloid leukemia with chronic lymphocytic leukemia.
    Colla S; Sammarelli G; Crugnola M; Ascani S; Sabbatini E; Bonomini S; Hojden M; Craviotto L; De Celis I; Morandi F; Caramatti C; Rizzoli V; Giuliani N
    Eur J Haematol; 2004 May; 72(5):361-5. PubMed ID: 15059073
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of the IMP-dehydrogenase inhibitor, Tiazofurin, in bcr-abl positive acute myelogenous leukemia. Part I. In vivo studies.
    Malek K; Boosalis MS; Waraska K; Mitchell BS; Wright DG
    Leuk Res; 2004 Nov; 28(11):1125-36. PubMed ID: 15380335
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Survival from adult leukaemia in England and Wales up to 2001.
    Milligan DW
    Br J Cancer; 2008 Sep; 99 Suppl 1(Suppl 1):S119-20. PubMed ID: 18813244
    [No Abstract]   [Full Text] [Related]  

  • 39. Rapid engraftment after allogeneic transplantation of density-enriched peripheral blood CD34+ cells in patients with advanced hematologic malignancies.
    Cao TM; Kusnierz-Glaz C; Valone F; Stockerl-Goldstein KE; Hu WW; Johnston L; Blume KG; Strober S; Negrin RS
    Cancer; 2001 Jun; 91(12):2205-13. PubMed ID: 11413507
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recent advancements in the treatment of chronic myelogenous leukemia.
    O'Dwyer ME; Mauro MJ; Druker BJ
    Annu Rev Med; 2002; 53():369-81. PubMed ID: 11818480
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.